Gene Expert MTB-RIF Ultra Test at Chughtai Lab

Gene Expert MTB-RIF Ultra at Chughtai Lab

Tuberculosis (TB) remains one of the most critical public health challenges globally, and particularly in Pakistan. To combat this infectious disease, Chughtai Lab offers the Gene Expert MTB-RIF Ultra test, a state-of-the-art molecular diagnostic assay that has revolutionized the detection of Mycobacterium tuberculosis (MTB) and the simultaneous identification of rifampicin resistance. Developed by Cepheid, this advanced cartridge-based nucleic acid amplification test (CBNAAT) represents a monumental leap forward from traditional smear microscopy and conventional culture techniques, providing rapid, highly sensitive, and specific results within a fraction of the time.

The clinical importance of the Gene Expert MTB-RIF Ultra test is paramount. Traditional diagnosis of tuberculosis often relied on sputum smear microscopy, which has low sensitivity and frequently misses cases with low bacterial loads, such as those in pediatric patients, individuals coinfected with HIV, and those with extrapulmonary tuberculosis. Conversely, mycobacterial culture, while highly sensitive, requires several weeks to yield results, delaying critical treatment decisions. The Gene Expert MTB-RIF Ultra assay bridges this gap by offering sensitivity comparable to culture while delivering results in a matter of hours. This rapid turnaround is crucial for initiating timely and appropriate anti-tuberculosis therapy (ATT), preventing transmission within the community, and identifying drug-resistant strains early in the diagnostic pathway.

The technology behind the Gene Expert MTB-RIF Ultra assay is based on real-time polymerase chain reaction (PCR). The test targets specific genomic sequences of the Mycobacterium tuberculosis complex, specifically focusing on the rpoB gene, which encodes the beta-subunit of RNA polymerase. Mutations within the highly conserved 81-base pair core region of this gene are responsible for approximately 95% of rifampicin resistance in MTB strains. Because rifampicin resistance is highly correlated with multidrug-resistant tuberculosis (MDR-TB), detecting rifampicin resistance serves as an invaluable surrogate marker for MDR-TB. The Ultra version of the cartridge incorporates several design improvements over its predecessor, including a larger chamber for DNA amplification, nested PCR, and the addition of two multi-copy insertion sequences, IS6110 and IS1081. These enhancements lower the limit of detection to just 16 colony-forming units (cfu) per milliliter, significantly improving diagnostic yield in challenging clinical scenarios.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest accuracy of the Gene Expert MTB-RIF Ultra test at Chughtai Lab, proper patient preparation and sample collection are essential. While the test does not require fasting or complex dietary restrictions, patients must adhere to specific guidelines to avoid sample contamination and ensure an adequate volume of diagnostic material:

• Sputum Collection: The most common specimen for pulmonary tuberculosis is sputum. Patients should collect an early morning sample, as this represents secretions accumulated overnight and contains the highest concentration of mycobacteria.
• Oral Hygiene: Before collecting the sample, the patient must rinse their mouth thoroughly with plain water to remove food particles, superficial bacteria, and oral debris. Do not use commercial mouthwash or toothpaste immediately before collection, as chemical residues may interfere with the PCR reaction.
• Deep Cough Technique: The specimen must be deep sputum from the lungs, not saliva or nasopharyngeal secretions. The patient should sit or stand comfortably, take several deep breaths, hold the air for a few seconds, and then cough deeply from the chest to expectorate into the sterile container provided by Chughtai Lab.
• Sterile Container: Only use the sterile, wide-mouthed container supplied by the laboratory. Do not touch the inside of the container or the lid to maintain sterility.
• Sample Volume: A minimum volume of 1 to 2 milliliters of purulent or mucopurulent sputum is required for optimal analysis. Salivary or watery specimens are inadequate and may lead to false-negative results.
• Extrapulmonary Samples: For non-sputum specimens, such as cerebrospinal fluid (CSF), pleural fluid, gastric aspirates, or fine-needle aspiration biopsy (FNAB) material, the collection must be performed by a qualified medical specialist in a clinical setting. No specific patient preparation is required other than the standard protocols for these invasive procedures.
• Medication History: Patients must inform the laboratory staff and their physician if they are currently taking anti-tuberculosis medications, as prior therapy can affect the viability of the DNA detected, though PCR can still detect non-viable bacterial DNA.

During the Procedure

The procedure for the Gene Expert MTB-RIF Ultra test at Chughtai Lab is designed to be seamless, safe, and highly efficient. Once the specimen is collected, it is processed in Chughtai Lab’s specialized molecular pathology division under strict biosafety conditions:

• Specimen Submission: The patient or healthcare provider submits the labeled specimen container to the nearest Chughtai Lab collection center. The sample is immediately logged into the laboratory information management system (LIMS) to ensure traceability.
• Laboratory Processing: Inside the molecular laboratory, a trained technologist works within a Class II Biosafety Cabinet to minimize aerosol exposure. The sputum sample is mixed with a specialized Sample Reagent (SR) containing sodium hydroxide and isopropanol in a 2:1 ratio. This reagent liquefies the sputum and inactivates the mycobacteria, rendering the sample non-infectious and safe for subsequent handling.
• Incubation: The mixture is incubated at room temperature for 15 minutes, with periodic shaking to ensure complete liquefaction and inactivation.
• Cartridge Loading: Using a sterile pipette, a specific volume of the liquefied sample (typically 2 ml) is transferred directly into the single-use, disposable GeneXpert cartridge. The cartridge is then sealed.
• Instrument Insertion: The cartridge is loaded into the Cepheid GeneXpert instrument. The rest of the process is fully automated and self-contained within the cartridge, eliminating the risk of cross-contamination between samples.
• Automated PCR: The instrument performs automated cell lysis to release genomic DNA, captures the DNA on a physical filter, washes away inhibitors, mixes the DNA with dry PCR reagents, and initiates real-time PCR amplification.
• Optical Detection: As the PCR cycles progress, fluorescent probes (molecular beacons) bind to the target DNA sequences. The instrument’s optical system measures the fluorescence in real-time, analyzing the hybridization of probes to the rpoB gene and the insertion sequences.
• Duration: The automated run inside the instrument takes approximately 80 minutes. The entire process, from sample receipt to initial data analysis, is typically completed within a few hours.
• Safety and Quality Control: The cartridge contains internal controls, including a Sample Processing Control (SPC) to verify adequate lysis and PCR amplification, and a Probe Check Control (PCC) to monitor reagent rehydration and optical system performance.

When is a Gene Expert MTB-RIF Ultra Performed?

Suspected Pulmonary Tuberculosis

Physicians request the Gene Expert MTB-RIF Ultra test when a patient presents with clinical symptoms suggestive of active pulmonary tuberculosis. These symptoms classically include a persistent, productive cough lasting more than two weeks, hemoptysis (coughing up blood), unexplained weight loss, drenching night sweats, low-grade evening fever, and chronic fatigue. In regions with a high burden of TB, such as Pakistan, rapid identification is paramount. The test assists diagnosis by confirming the presence of Mycobacterium tuberculosis DNA directly from sputum, allowing clinicians to initiate treatment immediately rather than waiting weeks for culture results.

Evaluation of Drug-Resistant TB (MDR-TB)

Drug-resistant tuberculosis is a major clinical challenge that complicates treatment and increases mortality. The Gene Expert MTB-RIF Ultra test is indicated for patients who are at high risk of drug resistance, including those who have previously failed TB treatment, those who have relapsed after completing therapy, or individuals who have been in close contact with known multidrug-resistant TB patients. By targeting the rpoB gene, the test rapidly identifies mutations that confer resistance to rifampicin. Because rifampicin resistance is a reliable surrogate marker for multidrug resistance, this test allows physicians to immediately bypass standard first-line regimens and design appropriate second-line treatment protocols.

Extrapulmonary Tuberculosis Diagnosis

Tuberculosis can manifest outside the lungs, affecting organs such as the brain (tuberculous meningitis), lymph nodes (tuberculous lymphadenitis), pleura (pleural TB), joints, and abdomen. Diagnosing extrapulmonary TB is notoriously difficult because these specimens often contain very low numbers of bacteria (paucibacillary samples). The Gene Expert MTB-RIF Ultra test is highly indicated for testing cerebrospinal fluid (CSF), lymph node aspirates, and other tissue biopsies. Its enhanced sensitivity, driven by the multi-copy targets IS6110 and IS1081, allows for the detection of minute quantities of bacterial DNA, providing a rapid and definitive diagnosis in life-threatening conditions like tuberculous meningitis.

HIV-Associated Tuberculosis

In individuals living with HIV, the immune system is severely compromised, altering the clinical presentation of tuberculosis. HIV-positive patients often present with smear-negative pulmonary TB or extrapulmonary disease, making traditional sputum smear microscopy highly unreliable. The World Health Organization (WHO) strongly recommends the Gene Expert MTB-RIF Ultra as the initial diagnostic test for all individuals living with HIV who show signs or symptoms of TB. The test’s low limit of detection ensures that even patients with minimal bacillary shedding are accurately diagnosed, facilitating early therapeutic intervention and reducing mortality in this vulnerable population.

Pediatric Tuberculosis Evaluation

Diagnosing tuberculosis in children is exceptionally challenging. Pediatric patients rarely produce sputum, and when they do, the sample is typically paucibacillary. Consequently, pediatric TB is often diagnosed presumptively, leading to both over-treatment and under-treatment. The Gene Expert MTB-RIF Ultra test is performed on alternative specimens in children, such as gastric aspirates, induced sputum, or stool samples. The high sensitivity of the Ultra cartridge is particularly beneficial in pediatric medicine, as it can detect very low concentrations of MTB DNA, providing objective laboratory confirmation of TB in children and guiding pediatricians in prescribing precise therapeutic regimens.

What Does a Gene Expert MTB-RIF Ultra Detect?

The Gene Expert MTB-RIF Ultra test is a comprehensive molecular assay that detects several critical biological and genetic markers. The specific findings and parameters detected by this advanced diagnostic technology include:

• Presence of Mycobacterium tuberculosis complex DNA in the clinical specimen.
• Absence of Mycobacterium tuberculosis complex DNA, indicating no detectable infection.
• Mutations in the rpoB gene core region, signifying resistance to rifampicin.
• Wild-type rpoB gene sequence, indicating susceptibility to rifampicin.
• Indeterminate rifampicin resistance, which occurs when the bacterial load is extremely low (such as “trace” detection) and resistance mutations cannot be reliably evaluated.
• “Trace” detection of MTB DNA, a unique feature of the Ultra cartridge indicating an extremely low bacterial concentration, common in pediatric, HIV-positive, and extrapulmonary samples.
• High semi-quantitative bacterial load of Mycobacterium tuberculosis.
• Medium semi-quantitative bacterial load of Mycobacterium tuberculosis.
• Low semi-quantitative bacterial load of Mycobacterium tuberculosis.
• Very low semi-quantitative bacterial load of Mycobacterium tuberculosis.
• Sample processing errors, detected via the internal Sample Processing Control (SPC).
• Reagent degradation or optical malfunctions, detected via the Probe Check Control (PCC).
• Presence of target DNA in extrapulmonary fluids, including cerebrospinal fluid (CSF).
• Presence of target DNA in lymph node aspirates and tissue biopsies.
• Presence of target DNA in gastric lavage or gastric aspirate specimens.
• Differentiation between viable/non-viable MTB DNA and non-tuberculous mycobacteria (NTM) (by specifically targeting MTB-complex sequences, though it does not detect NTMs).
• Integrity of the assay chemistry, ensuring no false positives from environmental contamination.
• Presence of the IS6110 insertion sequence, specific to the Mycobacterium tuberculosis complex.
• Presence of the IS1081 insertion sequence, further confirming the presence of MTB complex DNA.
• Amplification curves of molecular beacons, providing quantitative real-time data.
• Melting temperature (Tm) shifts in the rpoB gene probes, which pinpoint the exact nature of the genetic mutation.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is renowned for its efficient, accurate, and patient-centric diagnostic services across Pakistan. Understanding the urgency associated with tuberculosis diagnosis, the molecular pathology department at Chughtai Lab prioritizes the processing of Gene Expert MTB-RIF Ultra samples. The standard turnaround time for this test is typically within 24 to 48 hours from the time of sample collection, depending on the location of the collection center and transport logistics to the central molecular reference laboratory.

To enhance patient convenience, Chughtai Lab offers multiple avenues for accessing diagnostic reports. Once the report is finalized and verified by a consultant pathologist, patients receive an automated SMS notification containing a direct link to download their report. Reports can also be accessed securely through the official Chughtai Lab mobile application (available on iOS and Android) or via the patient portal on the official Chughtai Lab website. For patients who prefer physical copies, reports can be collected directly from any Chughtai Lab collection center, or they can opt for home delivery services. This rapid and accessible reporting system ensures that patients and their treating physicians can make immediate, informed clinical decisions.

Gene Expert MTB-RIF Ultra Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Mycobacterium tuberculosis (MTB) DNA	Not Detected	Detected (High, Medium, Low, Very Low, or Trace)
Rifampicin Resistance	Not Detected (Susceptible)	Detected (Resistant) or Indeterminate
rpoB Gene Status	Wild-type sequence (No mutations)	Mutation detected in the 81-bp core region
IS6110 & IS1081 Insertion Sequences	Not Amplified	Amplified (Confirms MTB complex presence)
Sample Processing Control (SPC)	Passed (Valid run)	Failed (Invalid run due to PCR inhibitors or poor lysis)
Probe Check Control (PCC)	Passed (Valid reagents)	Failed (Reagent degradation or optical error)
Semi-quantitative Bacterial Load	None	High, Medium, Low, Very Low, or Trace concentration
Extrapulmonary Specimen Analysis	Negative for MTB DNA	Positive for MTB DNA (indicates extrapulmonary TB)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Gene Expert MTB-RIF Ultra?

• ISO 15189 Certified Laboratories: Chughtai Lab operates under strict international quality management standards, ensuring highly accurate and reliable molecular diagnostic results.
• Advanced Molecular Pathology Department: Equipped with state-of-the-art Cepheid GeneXpert systems, managed by highly trained molecular biologists and technologists.
• Expert Consultant Pathologists: All molecular reports are reviewed and verified by experienced pathologists specializing in infectious disease diagnostics and molecular genetics.
• Nationwide Network: With hundreds of collection centers across Pakistan, patients can easily access testing facilities in major cities and remote areas alike.
• Convenient Home Sample Collection: Chughtai Lab provides professional home sampling services, allowing patients to submit specimens from the comfort of their homes.
• Rapid Digital Report Access: Patients can view, download, and share their reports instantly via the Chughtai Lab mobile app, website portal, or SMS links.
• Strict Biosafety Protocols: The laboratory adheres to international biosafety standards (Class II cabinets) to protect staff, patients, and the community during sample processing.
• Patient-Centric Care: Offering compassionate service, clear instructions, and dedicated customer support to guide patients through their diagnostic journey.